These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9152730)

  • 21. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone for tardive dyskinesia.
    Chen JY; Bai YM; Pyng LY; Lin CC
    Am J Psychiatry; 2001 Nov; 158(11):1931-2. PubMed ID: 11691710
    [No Abstract]   [Full Text] [Related]  

  • 25. Dysphagia: a rare form of dyskinesia?
    Nieves JE; Stack KM; Harrison ME; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vitamin E is ineffective in treatment of late dyskinesias].
    Bridler R
    Praxis (Bern 1994); 2001 May; 90(18):809-10. PubMed ID: 11392285
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical profile of an atypical antipsychotic: risperidone.
    Davis JM; Chen N
    Schizophr Bull; 2002; 28(1):43-61. PubMed ID: 12047021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic-induced respiratory dyskinesia.
    Kruk J; Sachdev P; Singh S
    J Neuropsychiatry Clin Neurosci; 1995; 7(2):223-9. PubMed ID: 7626967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education.
    Chaplin R; Timehin C
    Aust N Z J Psychiatry; 2002 Feb; 36(1):99-103. PubMed ID: 11929445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute, progressive akinetic-rigid syndrome induced by neuroleptics in a case of Wilson's disease.
    Chroni E; Lekka NP; Tsibri E; Economou A; Paschalis C
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):531-2. PubMed ID: 11748326
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 33. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone and tardive dyskinesia: a case report.
    Addington DE; Toews JA; Addington JM
    J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377
    [No Abstract]   [Full Text] [Related]  

  • 36. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of clozapine on tardive dyskinesia.
    Lieberman JA; Saltz BL; Johns CA; Pollack S; Borenstein M; Kane J
    Br J Psychiatry; 1991 Apr; 158():503-10. PubMed ID: 1675900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ECT, emergent dyskinesia, and depression.
    Flaherty JA; Naidu J; Dysken M
    Am J Psychiatry; 1984 Jun; 141(6):808-9. PubMed ID: 6145361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of debilitating tardive dyskinesia with risperidone.
    Rangwani SR; Gupta S; Burke WJ; Potter J
    Ann Clin Psychiatry; 1996 Mar; 8(1):27-9. PubMed ID: 8743646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study.
    Procyshyn RM; Barr AM; Flynn S; Schenk C; Ganesan S; Honer WG
    Schizophr Res; 2010 Nov; 123(2-3):273-5. PubMed ID: 20688481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.